Literature DB >> 11764777

Progress in HIV vaccine development.

M I Johnston1, J Flores.   

Abstract

Recent advances in HIV vaccine development include initiation of the first efficacy trials and substantial expansion of the preclinical pipeline. Several preclinical candidate vaccines have induced strong cellular immune responses and provided impressive protection against AIDS in non-human primate models; however, candidates that induce broadly neutralizing antibodies remain elusive.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11764777     DOI： 10.1016/s1471-4892(01)00086-8

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN： 1471-4892            Impact factor:   5.547


  7 in total

1.  The second wave will drown us.

Authors:  Michael Gross
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

2.  A susceptible-infected epidemic model with voluntary vaccinations.

Authors:  Frederick H Chen
Journal:  J Math Biol       Date:  2006-06-07       Impact factor: 2.259

3.  Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strain.

Authors:  Ying Lian; Indresh Srivastava; V Rául Gómez-Román; Jan Zur Megede; Yide Sun; Elaine Kan; Susan Hilt; Susan Engelbrecht; Sunee Himathongkham; Paul A Luciw; Gillis Otten; Jeffrey B Ulmer; John J Donnelly; Dietmar Rabussay; David Montefiori; Estrelita Janse van Rensburg; Susan W Barnett
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  HIV Vaccines: Biological and Clinical Considerations.

Authors:  M. Patricia D'Souza; Mary A. Allen; Margaret I. Johnston
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.725

Review 5.  Viral sequence diversity: challenges for AIDS vaccine designs.

Authors:  Sean P McBurney; Ted M Ross
Journal:  Expert Rev Vaccines       Date:  2008-11       Impact factor: 5.217

Review 6.  FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review.

Authors:  E W Uhl; T G Heaton-Jones; R Pu; J K Yamamoto
Journal:  Vet Immunol Immunopathol       Date:  2002-12       Impact factor: 2.046

7.  Industry, innovation and social values.

Authors:  Harvey E Bale
Journal:  Sci Eng Ethics       Date:  2005-01       Impact factor: 3.525
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.